Total Payments
$3,236
2024 Payments
$489.86
Companies
25
Transactions
188
Medicare Patients
1,444
Medicare Billing
$249,614
Payment Breakdown by Category
Food & Beverage$2,923 (90.3%)
Travel$313.03 (9.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,923 | 185 | 90.3% |
| Travel and Lodging | $313.03 | 3 | 9.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Collegium Pharmaceutical, Inc. | $695.18 | 60 | $0 (2024) |
| Nevro Corp. | $618.52 | 26 | $0 (2023) |
| Curonix LLC | $455.08 | 5 | $0 (2024) |
| PFIZER INC. | $217.10 | 16 | $0 (2019) |
| Purdue Pharma L.P. | $194.53 | 18 | $0 (2018) |
| BioDelivery Sciences International, Inc. | $183.43 | 12 | $0 (2021) |
| Daiichi Sankyo Inc. | $159.07 | 11 | $0 (2019) |
| Depomed, Inc. | $128.23 | 8 | $0 (2017) |
| PROTEGA PHARMACEUTIALS INC | $89.24 | 2 | $0 (2023) |
| Abbott Laboratories | $88.73 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $489.86 | 21 | Curonix LLC ($304.58) |
| 2023 | $542.52 | 23 | Collegium Pharmaceutical, Inc. ($191.85) |
| 2022 | $230.94 | 19 | Collegium Pharmaceutical, Inc. ($161.00) |
| 2021 | $69.27 | 6 | BioDelivery Sciences International, Inc. ($25.57) |
| 2020 | $52.30 | 4 | Collegium Pharmaceutical, Inc. ($28.88) |
| 2019 | $391.49 | 23 | BioDelivery Sciences International, Inc. ($88.36) |
| 2018 | $962.10 | 54 | Nevro Corp. ($516.27) |
| 2017 | $497.72 | 38 | Purdue Pharma L.P. ($168.65) |
All Payment Transactions
188 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Neuromodulation | ||||||
| 12/02/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $13.62 | General |
| Category: Opioid Analgesic | ||||||
| 11/14/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $4.96 | General |
| Category: Opioid Analgesic | ||||||
| 10/29/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $18.88 | General |
| Category: Opioid Analgesic | ||||||
| 09/24/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $3.52 | General |
| Category: Opioid Analgesic | ||||||
| 09/05/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $8.25 | General |
| Category: Opioid Analgesic | ||||||
| 08/27/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $11.42 | General |
| Category: Opioid Analgesic | ||||||
| 07/30/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $7.07 | General |
| Category: Opioid Analgesic | ||||||
| 07/09/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $12.50 | General |
| Category: Opioid Analgesic | ||||||
| 06/06/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $8.12 | General |
| Category: Opioid Analgesic | ||||||
| 05/21/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $10.14 | General |
| Category: Opioid Analgesic | ||||||
| 04/29/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $13.91 | General |
| Category: Opioid Analgesic | ||||||
| 04/13/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Travel and Lodging | Cash or cash equivalent | $242.68 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/13/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Travel and Lodging | Cash or cash equivalent | $46.60 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/13/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | Cash or cash equivalent | $15.30 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/01/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $7.51 | General |
| Category: Opioid Analgesic | ||||||
| 03/19/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $12.98 | General |
| Category: Opioid Analgesic | ||||||
| 03/19/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $2.53 | General |
| Category: Opioid Analgesic | ||||||
| 02/13/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $14.03 | General |
| Category: Opioid Analgesic | ||||||
| 01/30/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $9.33 | General |
| Category: Opioid Analgesic | ||||||
| 01/18/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $6.11 | General |
| Category: Opioid Analgesic | ||||||
| 12/19/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $10.26 | General |
| Category: Opioid Analgesic | ||||||
| 11/28/2023 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/20/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $15.80 | General |
| Category: Opioid Analgesic | ||||||
| 11/04/2023 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | In-kind items and services | $137.25 | General |
| Category: PAIN MANAGEMENT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 292 | 713 | $105,091 | $51,387 |
| 2022 | 7 | 335 | 853 | $118,841 | $60,158 |
| 2021 | 8 | 373 | 996 | $130,156 | $68,091 |
| 2020 | 6 | 444 | 1,034 | $149,642 | $69,978 |
Total Patients
1,444
Total Services
3,596
Medicare Billing
$249,614
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 131 | 482 | $56,480 | $30,209 | 53.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 87 | 145 | $25,105 | $14,012 | 55.8% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 27 | 34 | $12,670 | $3,188 | 25.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $6,263 | $2,944 | 47.0% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2023 | 21 | 26 | $4,573 | $1,034 | 22.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 149 | 578 | $66,730 | $36,539 | 54.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 98 | 167 | $28,433 | $15,439 | 54.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $6,303 | $3,250 | 51.6% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2022 | 20 | 28 | $11,236 | $2,818 | 25.1% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2022 | 17 | 24 | $4,149 | $1,042 | 25.1% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 14 | 19 | $1,859 | $1,008 | 54.2% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 13 | 13 | $130.00 | $62.60 | 48.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 167 | 697 | $80,469 | $45,934 | 57.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 87 | 138 | $23,341 | $14,245 | 61.0% |
| 64483 | Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance, single level | Facility | 2021 | 30 | 42 | $15,582 | $3,642 | 23.4% |
| 64484 | Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance, each additional level | Facility | 2021 | 29 | 41 | $5,939 | $1,805 | 30.4% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 16 | 21 | $2,055 | $1,155 | 56.2% |
| 20552 | Injections of trigger points in 1 or 2 muscles | Office | 2021 | 11 | 16 | $1,426 | $661.22 | 46.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 14 | 18 | $1,114 | $544.50 | 48.9% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2021 | 19 | 23 | $230.00 | $104.00 | 45.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 172 | 621 | $71,694 | $37,850 | 52.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 145 | 258 | $43,638 | $18,204 | 41.7% |
| 64483 | Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance | Office | 2020 | 17 | 17 | $6,307 | $3,458 | 54.8% |
| 64483 | Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance | Facility | 2020 | 29 | 37 | $13,727 | $3,440 | 25.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 19 | 19 | $4,970 | $2,543 | 51.2% |
About Dr. Priya Swamy, M.D
Dr. Priya Swamy, M.D is a Physical Medicine & Rehabilitation healthcare provider based in Broomall, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245285741.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Priya Swamy, M.D has received a total of $3,236 in payments from pharmaceutical and medical device companies, with $489.86 received in 2024. These payments were reported across 188 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($2,923).
As a Medicare-enrolled provider, Swamy has provided services to 1,444 Medicare beneficiaries, totaling 3,596 services with total Medicare billing of $249,614. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Broomall, PA
- Active Since 05/23/2006
- Last Updated 12/11/2024
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1245285741
Products in Payments
- Senza Spinal Cord Stimulation System (Device) $587.91
- XTAMPZA (Drug) $523.26
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) $455.08
- LYRICA (Drug) $202.68
- Morphabond ER (Drug) $159.07
- BUNAVAIL 2.1 mg 30-count box (Drug) $130.80
- Nucynta (Drug) $128.23
- HYSINGLA ER (Drug) $106.17
- Belbuca (Drug) $101.25
- ROXYBOND (Drug) $89.24
- SPRINT PNS System (Device) $66.00
- Xtampza ER (Drug) $58.19
- Proclaim Family of SCS IPGs (Device) $56.91
- BUTRANS (Drug) $55.34
- ZOHYDRO ER (Drug) $53.02
- Amitiza (Drug) $43.81
- Senza (Device) $30.61
- ARYMO ER (Drug) $26.24
- AJOVY (Drug) $26.03
- SYMPROIC (Drug) $25.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.